Life Science Investing NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog
